L'intérêt à découvert pour Avantor donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Avantor. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Avantor (NYSE:AVTR) Stock, Rapport sur les intérêts à découvert

AVANTOR INC

Avantor

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

<h3>Gainers</h3>
<ul>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) shares moved upwards by 133.1% to $136.34 during Thursday's regular session. The market value of their outstanding shares is at $354.7 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 51.98% to $1.18. The market value of their outstanding shares is at $120.3 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock rose 27.53% to $0.17. The market value of their outstanding shares is at $13.9 million. </li>
<li>FiEE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) shares moved upwards by 22.84% to $3.28. The company's market cap stands at $19.6 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock increased by 20.98% to $2.56. The company's market cap stands at $4.0 million. </li>
<li>SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) shares rose 16.27% to $27.44. The market value of their outstanding shares is at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) stock fell 14.6% to $0.25 during Thursday's regular session. The company's market cap stands at $18.7 million. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares decreased by 12.6% to $0.28. The company's market cap stands at $16.6 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock fell 10.13% to $12.87. The market value of their outstanding shares is at $25.0 million. </li>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock fell 8.92% to $5.46. The company's market cap stands at $7.6 million. </li>
<li>XIAO-I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) shares fell 7.46% to $2.54. The company's market cap stands at $36.3 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock decreased by 6.82% to $8.2. The company's market cap stands at $207.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AIRE

AIXI

ARBK

ASTI

BMNR

LCFY

MINM

SEDG

WOLF

12 Information Technology Stocks Moving In Thursday's Intraday Session

ClearOne Announces $3 Million Investment
&nbsp;
SALT LAKE CITY – July 03, 2025 – ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>), a global market leader in conferencing, collaboration, and network streaming solutions, announced on June 25, 2025, that it has recently sold $3 million of convertible notes, which represents an investment in the Company.
This investment was made in connection with the Company's ongoing strategic process and in support of its previously disclosed plan to pursue one or more transactions. Along with the investment, ClearOne has implemented a restructuring that will eliminate a portion of its workforce as part of a broader operational scaling initiative. During this process, ClearOne will continue selling and supporting its award-winning products, ensuring partners and customers receive the high-quality products and service they expect, while simultaneously executing the mission the company has been directed to accomplish by its Board to maximize shareholder value.

News

Contracts

Management

CLRO

ClearOne Secures $3M Investment By Sale Of Convertible Notes; Announces Workforce Restructuring To Support Strategic Growth Initiatives

Macro Economic Events

Econ #s

Economics

U.S. Baker Hughes Oil Rig Count -7 To 425; U.S. Baker Hughes NatGas Rig Count -1 To 108; U.S. Baker Hughes Total Rig Count 539 Vs 547 Prior

Billionaire Mark Cuban is doubling down on his idea that medical school in the U.S. should be tuition-free. &#8220;There are 100k students in med school each year. Room and board is about 100k per year. For $10B a year, med school could be free,&#8221; Cuban said recently on <a href="https://bsky.app/profile/mcuban.bsky.social/post/3ls5urzyfys2v">Bluesky</a>.
<h2 class="wp-block-heading">A Bold Proposal With Economic Upside</h2>
Cuban believes this kind of investment &#8220;would see a wholesale change in the profession, career paths and the cost of care.&#8221; He argues that high education costs force students to make financial decisions that limit their options and ultimately hurt the healthcare system.
Don't Miss:
<ul class="wp-block-list">
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
<li>GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a></li>
</ul>
This isn&#8217;t a new idea for him. Back in December, Cuban floated a similar plan, saying the government could fund <a href="https://www.benzinga.com/news/24/12/42678209/free-medical-school-for-all-mark-cuban-says-its-doable-for-just-2-5-billion-a-year-is-it-an-expense-or-a-strategic-cost-saving-move">free medical school</a> for under $2.5 billion a year. At the time, Cuban estimated the cost by multiplying the number of students by average expenses, noting there are fewer than 25,000 medical students in the U.S. and average annual costs are typically below $100,000 per student.
He also suggested that private companies might be willing to cover students&#8217; education in exchange for post-graduate employment, especially as AI and other technologies reshape health care.
<h2 class="wp-block-heading">Pushback From Congress</h2>
Cuban's renewed comments came as the Senate passed a <a href="https://www.benzinga.com/news/politics/25/06/46161747/thom-tillis-pulls-out-of-2026-re-election-run-after-saying-he-cannot-support-trump-backed-one-big-beautiful-bill-president-calls-it-great-news">tax bill</a> on July 1 that includes, among other things, new limits on how much students can borrow for medical and other professional degrees. It is now before the House for final approval. The proposed cap is $200,000, well below the real cost of attending med school.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<a href="https://store.aamc.org/medical-student-education-debt-costs-and-loan-repayment-fact-card-for-the-class-of-2024.html">According to</a> the Association of American Medical Colleges, the median cost for the class of 2025 is $286,454 at public institutions and $390,848 at private ones.
Many in the medical field say these changes could shut out low-income and first-generation students, push them toward private loans with worse terms, and worsen the doctor shortage, especially in rural and primary care settings.
&#8220;When they come into medical education, more times than not, they don&#8217;t have co-signers,&#8221; Burrell College of Osteopathic Medicine President John L. Hummer told <a href="https://www.politico.com/news/2025/06/21/republican-medical-student-loan-limits-00415741">Politico</a>.
Sen. Roger Marshall (R-KS), who earned his medical degree in 1987 when tuition was a fraction of today's cost, wasn&#8217;t sympathetic. "Anyone who is paying more than $100,000 to go to school is making a huge mistake," he told Politico.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation.&nbsp;</a>
<h2 class="wp-block-heading">A Strategic Investment</h2>
Cuban frames free medical education as a smart long-term investment. After all, more doctors could improve access to care and reduce delays, allowing illnesses to be caught and treated earlier, which would result in better health outcomes for many Americans.
In February 2024, that vision came to life in one corner of the country. Ruth Gottesman, widow of Warren Buffett's longtime associate David Gottesman, <a href="https://www.benzinga.com/news/24/02/37348692/ruth-gottesman-donates-1b-to-medical-school-how-warren-buffett-berkshire-hathaway-factor-into-this-i">donated $1 billion</a> to the Albert Einstein College of Medicine in New York City, making tuition free for all future students.
And a <a href="https://www.benzinga.com/personal-finance/24/07/39709599/billionaire-bloombergs-1-billion-gift-makes-medical-school-free-at-johns-hopkins-should-other-bi">$1 billion donation</a> from Michael Bloomberg to Johns Hopkins University in Baltimore removes financial barriers for medical students from families making less than $300,000 per year. Living expenses are also covered for those earning less than $175,000.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Mark Cuban Says Med School Should Be Free—'For $10B A Year, We Would See A Change In The Profession, Career Paths, And The Cost Of Care'

B of A Securities analyst Ruplu Bhattacharya maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Buy and raises the price target from $100 to $110.

Price Target

Analyst Ratings

ROKU

B of A Securities Maintains Buy on Roku, Raises Price Target to $110

WIIM

LQR House shares are trading higher after announcing that an importer has placed its third major purchase order from the company, totaling 176 cases of SWOL tequila.

BellRing Brands's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) short percent of float has risen 11.86% since its last report. The company recently reported that it has 3.99 million shares sold short, which is 3.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>BellRing Brands Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751562062_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BellRing Brands has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing BellRing Brands's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, BellRing Brands's peer group average for short interest as a percentage of float is 6.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

BRBR

Is the Market Bullish or Bearish on BellRing Brands?

Textron's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) short percent of float has risen 23.75% since its last report. The company recently reported that it has 5.08 million shares sold short, which is 3.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Textron Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751562056_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Textron has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Textron's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Textron's peer group average for short interest as a percentage of float is 5.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Textron Gaining or Losing Market Support?

Cigna Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) short percent of float has risen 8.27% since its last report. The company recently reported that it has 2.95 million shares sold short, which is 1.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.64 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Cigna Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751562051_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cigna Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Cigna Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Cigna Group's peer group average for short interest as a percentage of float is 10.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Cigna Group?

Locafy shares are trading lower after the company received a Nasdaq notice for the delayed filing of its interim financials.

JBLU

Reuters Cites Filing Saying United Airlines, JetBlue Ask U.S. Transportation Department To Reject Spirit Airlines Complaint Over Partnership

Wolfspeed Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares are surging on Thursday following the company&#8217;s announcement on Monday that it has initiated a pre-packaged Chapter 11 bankruptcy filing.
What To Know: The semiconductor company, a leader in silicon carbide technology, is pursuing a <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46194475/why-wolfspeed-stock-is-ripping-higher-today">strategic restructuring</a> to significantly strengthen its financial position.
The restructuring plan, backed by a substantial majority of its lenders, including over 97% of senior secured noteholders and a subsidiary of Renesas Electronics Corporation, is designed to slash the company&#8217;s debt by approximately $4.6 billion, a reduction of about 70%. Wolfspeed also anticipates a 60% decrease in its annual cash interest payments upon emerging from the process.
CEO Robert Feurle <a href="https://investor.wolfspeed.com/news/news-details/2025/Wolfspeed-Takes-Next-Step-to-Implement-Restructuring-Support-Agreement-and-Proactively-Strengthen-Capital-Structure/default.aspx">stated</a> that the move will accelerate the company's path to profitability and better position it to meet the growing demands of the semiconductor market. &#8220;With a stronger financial foundation, Wolfspeed will be better positioned to move faster on our strategic priorities,&#8221; Feurle commented.
The company has emphasized that it will continue to operate as usual, delivering its silicon carbide materials and devices to customers without interruption. Wolfspeed expects to complete the restructuring and emerge from Chapter 11 by the end of the third quarter of 2025.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, WOLF shares are trading higher by 52.0% to $1.75 Thursday afternoon. The stock has a 52-week high of $25.49 and a 52-week low of $0.39.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46248233/robinhood-stock-pulls-back-from-all-time-highs-whats-going-on">Robinhood Stock Pulls Back From All-Time Highs: What&#8217;s Going On?</a>

Why Wolfspeed (WOLF) Stock Is Extremely Volatile Today

Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) <a href="https://www.benzinga.com/topic/alibaba" target="_blank" rel="noreferrer noopener">stock has surged 28%</a> year-to-date, topping the NYSE Composite&#8217;s 8% gain and the NYSE Arca China&#8217;s 18%. It has gained over 44% in the last twelve months.
The Chinese e-commerce giant&#8217;s core e-commerce and cloud businesses, strategic investments in artificial intelligence, and phase-out of non-core assets have been fueling the upside for the company, which is also deemed the tech barometer of China.
<h2 class="wp-block-heading">Cloud And AI</h2>
Specifically, the company&#8217;s Cloud Intelligence Group is experiencing accelerating growth, particularly in AI-related products, and its Qwen AI model family is gaining traction.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45925331/alibaba-co-founder-sees-open-source-qwen-driving-cloud-demand" rel="noreferrer noopener">Alibaba Co-Founder Sees Open-Source Qwen Driving Cloud Demand</a>
In June, Alibaba released its updated <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45975004/alibaba-updates-llms-to-power-ai-on-apple-devices-in-china" rel="noreferrer noopener">Qwen3 AI models</a>, aiming to unlock value by enabling Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to deploy machine-learning features on iPhones, iPads, and MacBooks in China.
This move supports Apple&#8217;s push to expand its Apple Intelligence suite in the region while aligning with China&#8217;s regulatory requirements for public AI model use.
Also in June, Alibaba&#8217;s Damo Academy and Zhejiang Cancer Hospital co-developed an <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46137326/alibabas-ai-model-outperforms-radiologists-in-early-gastric-cancer-detection" rel="noreferrer noopener">AI model, Grape</a>, to detect gastric cancer from 3D CT scans. The Grape model identifies early-stage stomach cancer and significantly outperforms radiologists, according to Nature Medicine.
Alibaba continues integrating AI into healthcare, building on its 2023 breakthrough in pancreatic cancer detection.
Alibaba is aggressively expanding its <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46215371/alibaba-cloud-opens-third-malaysia-data-center-plans-second-in-philippines" rel="noreferrer noopener">global cloud presence</a>, opening new data centers in Malaysia, South Korea, and the Philippines. By 2025, it plans to extend Qwen AI models and Model Studio globally and launch a global AI hub in Singapore.
The company aims to grow its cloud network across China, Asia, the Middle East, Europe, and the Americas over the next three years.
Backed by a $52 billion investment, Alibaba pushes international growth amid U.S. tensions and intensifies AI competition in China.
<h2 class="wp-block-heading">Market Share And Earnings</h2>
In 2025, the revenue in the smartphone market in China could reach $111.86 billion, <a target="_blank" href="https://www.statista.com/outlook/cmo/consumer-electronics/telephony/smartphones/china" rel="noreferrer noopener">as per</a> Statista, implying a compound annual growth rate (CAGR) of 5.31% from 2025 to 2030.
Revenue in the public cloud market worldwide could reach $980.30 billion in 2025, <a target="_blank" href="https://www.statista.com/outlook/tmo/public-cloud/worldwide" rel="noreferrer noopener">as per</a> Statista. The revenue could post an annual growth rate (CAGR 2025-2030) of 17.12%, resulting in a market volume of $2.16 trillion by 2030.
In May, Alibaba reported <a target="_blank" href="https://www.benzinga.com/25/05/45473543/alibabas-cloud-and-e-commerce-units-shine-as-analyst-sees-ai-take-rates-fueling-future-growth" rel="noreferrer noopener">fiscal fourth-quarter</a> revenue growth of 7% to $32.58 billion, missing the analyst consensus estimate of $33.08 billion. Revenue from Taobao and Tmall Group grew by 9% to $13.97 billion. Revenue from Alibaba International Digital Commerce Group increased by 22% to $4.63 billion. Cloud Intelligence Group revenue grew by&nbsp;18%&nbsp;to&nbsp;$4.15 billion.
While near-term margin pressure remains a concern, Benchmark&nbsp;analyst Fawne Jiang noted Alibaba as a leading beneficiary of accelerated AI adoption in China and a top structural player in the sector.
Alibaba&#8217;s <a target="_blank" href="https://www.benzinga.com/quote/BABA/analyst-ratings" rel="noreferrer noopener">consensus price forecast</a> is $146.81, based on the ratings of 17 analysts. With an average price forecast of $159.33, Alibaba&#8217;s implied upside from these most recent analyst ratings is 46.6%.
Price Action:&nbsp;BABA shares are trading lower by&nbsp;2.06% to&nbsp;$108.43 at&nbsp;last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46246152/iphone-sales-bounce-back-in-china-but-huawei-and-xiaomi-intensify-pressure" target="_blank" rel="noreferrer noopener">iPhone Sales Bounce Back In China, But Huawei And Xiaomi Intensify Pressure</a></li>
</ul>
Photo via Shutterstock

Asia

Tech

AAPL

BABA

Alibaba's AI And Cloud Moves Have Sparked 28% Stock Rebound

Plug Power inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are trading higher Thursday. The U.S. Senate extended a critical hydrogen production tax credit, providing a significant boost to the clean <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46202400/plug-power-stock-pulls-back-after-tax-credit-rally">energy sector on Monday.</a>
What To Know: According to Barron's, a revised version of the Senate's budget bill extended the construction start deadline for the Section 45V hydrogen tax credit to Dec. 31 2027. The deadline was previously set for Jan.1 2026 and its extension offers a lifeline to many hydrogen projects that were facing potential cancellation.
The credit provides up to $3 per kilogram for clean hydrogen production, a key incentive for companies like Plug Power that are working to build out hydrogen infrastructure. The unexpected two-year extension could drive new investments and restore momentum in a sector that had been weighed down by policy uncertainty. Just weeks ago, Plug Power's stock had been under pressure due to concerns that these credits could be phased out sooner under a Senate Finance Committee proposal. That concern had triggered multiple analyst downgrades and price target cuts across Wall Street.
While the stock had already started to rebound last week following company participation in investor events, Monday's policy development marks a more material shift. 
Despite the positive catalyst, Plug Power still faces a skeptical analyst community. Several firms have recently cut their price targets sharply, even while maintaining formal Hold or Underweight ratings. Jefferies trimmed its target to 90 cents, while Morgan Stanley and Piper Sandler lowered theirs to 50 and 80 cents, respectively. Wells Fargo also moved its target down to $1.
The stock is still down significantly from its 52-week high of $3.34 but has recovered from its 69-cent low as investors reassess the company's prospects in light of the new policy development.
PLUG Price Action: Plug Power shares were up 5.36% at $1.475 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/07/46244105/june-jobs-report-nonfarm-payroll-adp-data">Don&#8217;t Bury The US Labor Market Just Yet: June Jobs Report Beats Every Forecast</a></li>
</ul>
Image Via Shutterstock.

PLUG

What's Going On With Plug Power Shares This Week?

SharpLink Gaming Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) is trending on Thursday amid broader excitement surrounding Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) treasury strategies. Here&#8217;s what you <a href="https://www.benzinga.com/pressreleases/25/07/g46243787/sharplink-gaming-to-ring-nasdaq-closing-bell-on-july-7-2025-celebrating-ethereum-treasury-mileston">need to know</a>.
What To Know: Attention surrounding Ethereum treasury strategies comes as BitMine Immersion Technologies Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) shares are up another 75% on Thursday, adding to gains of more than 2,000% this week.
The company on Monday <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46167825/bitmine-immersion-technologies-stock-is-soaring-monday-whats-going-on">announced plans</a> to implement an Ethereum treasury strategy by acquiring ETH, the native cryptocurrency of the Ethereum blockchain. BitMine also appointed Fundstrat's&nbsp;Tom Lee&nbsp;as chairman. Lee discussed the move in interviews on multiple media outlets this week, which appears to be fueling excitement. 
"Stablecoins have proven to be the ‘chatGPT' of&nbsp;crypto, leading to rapid adoption by consumers, merchants and financial services providers," Lee said.&nbsp;"Ethereum&nbsp;is the blockchain where the majority of&nbsp;stablecoin&nbsp;payments are transacted … and thus,&nbsp;ETH&nbsp;should benefit from this growth."
SharpLink Gaming <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45620524/sharplink-gaming-stock-soars-after-company-adopts-ethereum-treasury-strategy-whats-happening">adopted Ethereum</a> as its primary treasury reserve asset&nbsp;in May. The micro-cap stock is up more than 300% since the announcement, despite trading well off its highs. 
SharpLink on Tuesday announced that the company strategically increased its total ETH holdings to 198,167 after acquiring an additional 9,468 ETH for&nbsp;approximately $22.83 million. The company also highlighted a recent capital raise and said it intends to use the proceeds to further increase its ETH treasury holdings. 
&#8220;We are entering a new era where digital assets like Ethereum are no longer speculative instruments – they are fast becoming the strategic currency of the modern digital economy,&#8221; said Joseph Lubin, chairman of Sharplink. Lubin is also one of the co-founders of Ethereum.
SharpLink noted this week that it has all of its ETH reserves deployed in staking protocols. The staking strategy generated 102 ETH in rewards from June 21 through June 27, the company said. 
SharpLink announced on Thursday that it will ring the closing bell&nbsp;at the Nasdaq on Monday to celebrate its Ethereum treasury strategy. 
&#8220;We believe Ethereum is integral to the next wave of financial innovation,&#8221; Lubin said. 
SBET Price Action:<a href="http://benzinga.com/quote/SBET"> SharpLink shares</a> traded up to around $14 in early trading Thursday before pulling back. The stock was up 5.89% at $12.68 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46202593/bitmine-bmnr-stock-soars-as-it-pivots-to-ethereum-treasury-appoints-tom-lee-chairman">BitMine (BMNR) Stock Soars As It Pivots To Ethereum Treasury, Appoints Tom Lee Chairman</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46242838/anthony-scaramucci-predicts-bitcoin-treasury-frenzy-will-fade">Anthony Scaramucci Predicts Bitcoin Treasury Frenzy &#8216;Will Fade&#8217;</a></li>
</ul>
Photo: J-Alone/Shutterstock.com

$ETH

SBET

SharpLink Gaming (SBET) Stock Is Trending Today: What's Going On?

<a href="https://www.bloomberg.com/news/articles/2025-07-03/nike-s-prices-may-go-higher-than-expected-after-trump-s-vietnam-trade-deal?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-03/nike-s-prices-may-go-higher-than-expected-after-trump-s-vietnam-trade-deal?embedded-checkout=true</a>

General

'Nike Likely to Raise Prices Even More After Vietnam Trade Deal'- Bloomberg

Dr. Vinay Prasad, the U.S. Food and Drug Administration&#8217;s (FDA) top vaccine official, overruled agency scientists to limit approval of two COVID-19 vaccines, despite internal recommendations to clear <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">them for broader use</a>.
The decision reflects a growing pattern of vaccine restrictions under the leadership of the U.S. Health and Human Services Secretary Robert F. Kennedy Jr.
FDA scientists had recommended full approval for updated COVID vaccines from Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) and Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) for individuals aged 12 and older, citing favorable risk-benefit analyses.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45887132/novavaxs-experimental-covid-19-influenza-combo-shot-shows-immune-response-among-older-adults-in-" rel="noreferrer noopener">Novavax&#8217;s Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial</a>
However, citing federal documents released Wednesday, ABC News reported <a target="_blank" href="https://abcnews.go.com/Health/wireStory/fda-vaccine-official-restricted-covid-vaccine-approvals-advice-123431749" rel="noreferrer noopener">that</a> Prasad restricted the shots to those at higher risk, seniors and people with underlying health conditions, arguing that declining hospitalization and death rates from COVID-19 shifted the balance of risks and benefits.
In a five-page memo, Prasad wrote that &#8220;even rare vaccination-related harms, both known and unknown, now have a higher chance of outweighing potential benefits,&#8221; highlighting the need for more cautious vaccine policy.
The vaccines were eventually approved in May, but under the narrower eligibility <a target="_blank" href="https://www.benzinga.com/government/regulations/25/05/45537919/fda-limits-annual-covid-19-boosters-to-high-risk-americans-demands-new-trials-for-healthy-adults-in-policy-shift-under-rfk-jr" rel="noreferrer noopener">criteria dictated by Prasad</a>.
Novavax&#8217;s shot, Nuvaxovid, is the only protein-based COVID vaccine available in the U.S., while Moderna&#8217;s mNexspike is a lower-dose, updated version of its <a target="_blank" href="https://www.benzinga.com/news/fda/25/06/45719840/modernas-new-covid-vaccine-secures-fda-clearance-for-seniors-at-risk-individuals" rel="noreferrer noopener">original mRNA-based vaccine</a>.
Prasad also cited the risk of myocarditis, a rare heart inflammation, especially in younger people, as a key reason for restricting Moderna&#8217;s shot.
He directed the company to conduct further studies as a condition for approval. The FDA also added updated warning labels for Moderna and Pfizer Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) vaccines regarding myocarditis, though external researchers say such cases are typically mild and resolve quickly.
Top FDA leaders rarely intervene in the product review, making Prasad&#8217;s decision notable. He was appointed in May after Dr. Peter Marks resigned over policy disagreements with Kennedy.
In May, Kennedy, in a&nbsp;video&nbsp;posted to the social media platform X, announced that the COVID-19 vaccine will no longer be among the recommended vaccines for pregnant women and healthy children on the U.S. Centers for Disease Control and <a target="_blank" href="https://www.benzinga.com/25/05/45624037/robert-f-kennedy-jr-says-cdc-drops-covid-vaccine-for-healthy-pregnant-women-kids" rel="noreferrer noopener">Prevention&#8217;s immunization schedule</a>.
Price Action: At the last check on Thursday, Moderna (MRNA) stock saw an increase of 1.34%, trading at $30.69, while Novavax (NVAX) stock rose by 0.67% to $6.81. Pfizer (PFE) stock was also up at the last check.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/contracts/25/07/46249640/astrazeneca-in-15b-talks-for-drug-that-could-upend-lung-cancer-treatment" target="_blank" rel="noreferrer noopener">AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment</a></li>
</ul>
Photo via Shutterstock

Biotech

Government

Large Cap

Health Care

MRNA

NVAX

RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval

BitMine Immersion Technologies shares are trading higher after the company on Monday announced a $250 million private placement to launch an Ethereum treasury strategy.

With rate cut hopes hogging the limelight, <a href="https://www.benzinga.com/etfs">dividend-based ETFs</a> might finally be experiencing their comeback time.
Investors are growing fond of high-yielding equity plays such as the Vanguard High Dividend Yield ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VYM#NYSE">VYM</a>) and Schwab U.S. Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>), as new labor market reports spark bets on a pivot by the Federal Reserve. With the bond market already <a href="https://www.benzinga.com/markets/equities/25/07/46228695/wall-street-today-sp500-bitcoin-price-trump-vietnam">pricing in a rate reduction through September</a>, and another likely in December, the old advantage of fixed-income yield may be waning, highlighting dividend-paying stocks again.
The catalyst? <a href="https://www.benzinga.com/markets/economic-data/25/07/46218795/labor-market-payrolls-june-interest-rates">Wednesday&#8217;s ADP employment report</a>, which revealed private employers lost 33,000 jobs in June, a surprising miss that represented the first contraction in more than two years. The steep drop fanned hopes the Fed will have to loosen policy ahead of schedule. 
Dividend ETFs are likely to sparkle when interest rates decline and investors look for defensive growth with regular cash flows. With inflation more-or-less stable and employment growth slowing (first monthly contraction since March 2023), SCHD and VYM look like the Goldilocks choices — neither too risky nor too dull.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/07/46246602/aots-new-sofl-etf-doubles-down-on-software-stocks-for-active-tech-traders">AOT&#8217;s New SOFL ETF Doubles Down On Software Stocks For Active Tech Traders</a>
<h1 class="wp-block-heading">Why It Matters</h1>
SCHD and VYM tilt toward stable, cash-surplus companies in sectors like consumer staples, healthcare and financials. They go for businesses that usually perform better in soft-landing or late-cycle situations.
In Thursday trading, SCHD crept 0.15% higher and VYM gained 0.6%, small moves that might hide a larger rotation underway in the background.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/07/46203728/quantum-ai-nuclear-three-frontiers-one-launchpad-powered-by-defiance-etfs">Quantum, AI, Nuclear: Three Frontiers, One Launchpad Powered By Defiance ETFs</a></li>
</ul>
Photo: NicoElNino via Shutterstock

Specialty ETFs

ETFs

SCHD

Soft US Jobs Report, Rate Cut Hopes May Bring Dividend ETFs Back In Style

ImmunoPrecise Antibodies shares are trading higher after the company announced its LENSai has achieved the ability to accurately predict binding on 17 previously unseen antibody-antigen complexes.

Press Releases

Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology

Avantor® to Present at TD Cowen's 45th Annual Health Care Conference

Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025

Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX

Earnings

Avantor® Reports First Quarter 2025 Results

Avantor® Announces CEO Transition

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Comments

Avantor

Intérêt court

Avantor (NYSE:AVTR) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL